Skip to content

Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate

Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate: The BASICS Trial

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05458960
Acronym
BASICS
Enrollment
3
Registered
2022-07-14
Start date
2025-03-28
Completion date
2025-11-17
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Colposcopy, Cervical cancer prevention, Adherence to follow-up, Unmet social needs, Distress

Brief summary

The investigators will perform a randomized controlled trial in which 72 eligible patients (low-income, uninsured, or on Medicaid) who are referred for colposcopy at Washington University School of Medicine, are enrolled and then screened for unmet social needs and distress. The participants will then be randomized 1:1 into either receive the social needs navigator program (n=36) or enhanced usual care (n=36).

Interventions

BEHAVIORALSocial needs navigator program

4 months of assistance tailored to the needs of the participant

BEHAVIORALEnhanced usual care

Referral to United Way 2-1-1

Sponsors

Washington University School of Medicine
Lead SponsorOTHER
National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Abnormal cervical cancer screen * Missed appointment at BJH colposcopy clinic and need to reschedule * Age 21 years or older * Able to provide verbal consent * Diagnosis of an abnormal cervical screen confirmed by cytology or pathology

Exclusion criteria

* Individual without a cervix * Known diagnosis or history of cancer * Unable to consent

Design outcomes

Primary

MeasureTime frame
Adherence to Colposcopy Visit as Measured as Number of Participants Who Complete Colposcopy Visit Within 6 Weeks After EnrollmentFrom enrollment through 6 weeks after enrollment

Secondary

MeasureTime frameDescription
Total Number of Unmet Basic Needs4 months after enrollment-Unmet basic needs include food security, housing, personal safety, neighborhood safety, sufficient money for necessities, childcare (if applicable), and transportation. A questionnaire will be given to participants to identify the number of unmet basic needs the participant has.
Change in General Distress Score as Measured by the NCCN Distress Thermometer and Problem ListEnrollment and 4 months after enrollmentParticipants will be asked to rate the amount of distress (scale of 0 to 10, 10=extreme distress) that they have experienced in the past week and the amount of distress (scale of 0 to 10) that they attribute to their abnormal cervical cancer screen. The NCCN distress problem list is a 40-item list categorized into five themes-practical, family, emotional, spiritual, and physical problems¬-and leaves room for patients to describe "other". A higher score indicates the greater the amount of distress.
Intent to Use Intervention Over TimeCompletion of study enrollment (estimated to be 18 months)-Providers are asked after completion of enrollment to indicate on a scale of 1=not committed to 10=fully committed of how committed they are to use the intervention in their clinic.
Patients' Satisfaction With InterventionCompletion of study enrollment (estimated to be 18 months)-The interview guide has two questions that relate to patient satisfaction related to the intervention. 1) Was the \[community health worker or 2-1-1 operator\] helpful to you? 2) Would you recommend \[the community healthworker/2-1-1\] to a family member or friend?
Providers' Satisfaction With InterventionCompletion of study enrollment (estimated to be 18 months)-Providers are asked after completion of enrollment to indicate their satisfaction with the intervention. They are given 12 statements about the satisfaction of the intervention and are asked to circle responses of 1=completely disagree, 2=disagree, 3=neither agree nor disagree, 4=agree, or 5=completely agree. The higher the score the more satisfied the provider is with the intervention.
Resources Needed to Sustain InterventionCompletion of study enrollment (estimated to be 18 months)-Validated questionnaire that will be administered to providers, staff, and community health workers: Self-administered 15-minute online survey that will be completed at the end of the study enrollment period. The survey will ask about specific implementation outcomes using the Acceptability Intervention Measure, the Intervention Appropriateness Measure, and the Feasibility of Intervention Measure.
Likelihood That Intervention Will Become Built Into Usual CareCompletion of study enrollment (estimated to be 18 months)-Providers are asked after completion of enrollment to indicate the likelihood that the intervention can be built into usual care in their clinic. The responses are either likely, very likely, neutral, unlikely, very unlikely, or unsure.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLindsay M Kuroki, M.D.

Washington University School of Medicine

Baseline characteristics

Characteristic
Age, Continuous54 years
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
1 Participants
Region of Enrollment
United States
3 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 20 / 1
other
Total, other adverse events
0 / 20 / 1
serious
Total, serious adverse events
0 / 20 / 1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026